Belizatinib
Belizatinib is an effective, oral and dual inhibitor of ALK (IC50: 0.7 nM, wild-type recombinant ALK) and TRKA, TRKB, and TRKC.
| Catalog Number | T4257 |
| Alternative Name(s) | TSR-011 |
| Research Area | Tyrosine Kinase/Adaptors|||Angiogenesis |
| Molecular Formula | C33H44FN5O3 |
| CAS# | 1357920-84-3 |
| Purity | 99.48% |
| SMILES | CC(C)NC(=O)[C@H]1CC[C@H](CC1)n1c(NC(=O)c2ccc(F)cc2)nc2ccc(CN3CCC(CC3)C(C)(C)O)cc12 |
| Size | 50 mg |
| Supplier Page | https://www.targetmol.com/compound/Belizatinib |
| Additional Information | https://www.targetmol.com/datasheet/T4257 |